Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. (Q41017566)
Jump to navigation
Jump to search
scientific article published on August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. |
scientific article published on August 1998 |
Statements
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo (English)
Kubota T
Koshizuka K
Williamson EA
Asou H
Said JW
Holden S
Miyoshi I
1 August 1998